BlackRock Group’s Kyntra Bio KYNB Stock Holding History

BlackRock Group’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.36M	Buy	2,540 +258	+11%	+$129K	﹤0.01%	1986
2016 Q3	$1.18M	Buy	2,282 +588	+35%	+$277K	﹤0.01%	1941
2016 Q2	$695K	Buy	1,694 +429	+34%	+$196K	﹤0.01%	2136
2016 Q1	$673K	Buy	1,265 +232	+22%	+$116K	﹤0.01%	2107
2015 Q4	$787K	Buy	1,033 +193	+23%	+$128K	﹤0.01%	2016
2015 Q3	$460K	Sell	840 -157	-16%	-$95.1K	﹤0.01%	2239
2015 Q2	$586K	Buy	+997	New	+$580K	﹤0.01%	2210
2015 Q1	–	Sell	-312	Closed	-$213K	–	2859
2014 Q4	$213K	Buy	+312	New	+$201K	﹤0.01%	2515

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Group's KYNB Position: Q4 2016 in Review

BlackRock Group increased its Kyntra Bio (KYNB) stake by 11% in Q4 2016, buying an estimated $129K and bringing the position to 2,540 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

BlackRock Group first reported a position in KYNB in Q4 2014 and has held it in 8 quarters since. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

BlackRock Group held 2,540 shares of Kyntra Bio worth $1.36M as of Q4 2016.
BlackRock Group bought 258 Kyntra Bio shares in Q4 2016, an estimated $129K.
Kyntra Bio made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1986 holding.
BlackRock Group first reported a position in Kyntra Bio in Q4 2014 and has held it in 8 quarters since.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.